Article info

Download PDFPDF

Original research
FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion

Authors

  • Robert J Oldham Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK PubMed articlesGoogle scholar articles
  • C Ian Mockridge Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK PubMed articlesGoogle scholar articles
  • Sonya James Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK PubMed articlesGoogle scholar articles
  • Patrick J Duriez Southampton Experimental Cancer Medicine/CRUK Centre, Protein Core Facility, University of Southampton Faculty of Medicine, Southampton, UK PubMed articlesGoogle scholar articles
  • H T Claude Chan Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK PubMed articlesGoogle scholar articles
  • Kerry L Cox Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK PubMed articlesGoogle scholar articles
  • Vicentiu A Pitic Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK PubMed articlesGoogle scholar articles
  • Martin J Glennie Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK PubMed articlesGoogle scholar articles
  • Mark S Cragg Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, Hampshire, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Mark S Cragg; msc{at}soton.ac.uk
View Full Text

Citation

Oldham RJ, Mockridge CI, James S, et al
FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion

Publication history

  • Accepted May 1, 2020
  • First published June 17, 2020.
Online issue publication 
June 17, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.